Viracta Therapeutics, Inc. - Bathi mangsa ngarep VIRX

VIRX (Viracta Therapeutics Inc.) - tandha merek perusahaan

Viracta Therapeutics (VIRX) enjoys a high level of credibility within the oncology community due to its precision approach to therapy. The profit change forecast on the GURU.Markets base chart, where the value represents the latest figure, confirms this status. Viracta Therapeutics is commercializing virus activation methods to destroy tumors, while unique patents protect its market niche from generics.

VIRX: Bathi mangsa ngarep Viracta Therapeutics 04.07.2022 - 18.11.2026

Viracta Therapeutics Inc. - rincian analitis lan metrik utama (VIRX)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:Viracta Therapeutics, Inc.
Barang utama Viracta Therapeutics, Inc.

For Viracta Therapeutics (VIRX), the forward profitability trend reflects the discounted value of expected operating income. This indicator measures the fundamental attractiveness of the business through projected future cash flows. The metric's dynamics are sensitive to cross-market correlations, signaling a potential asset revaluation. For this leader in EBV-oncology therapy, growth in this indicator confirms the commercial potential of the "Kick and Kill" technology. This allows for an assessment of the investment value of developing drugs for the treatment of rare lymphomas.

Pesaing wigati

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Bathi sing dikarepake|Checkpoint Therapeutics, Inc (CKPT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Elevation Oncology, Inc.|ICAD: Penghasilan resik sing dikarepake|Bathi sing dikarepake ikenaoncology.com (IKNA)|Bathi sing dikarepake NTBL (Notable Labs, Ltd.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake